The most important component of diagnosing erectile dysfunction is obtaining a complete medical and sexual history. It is important to distinguish the condition from other sexual dysfunctions, such as premature ejaculation and loss of libido.
The erectile dysfunction drugs market is categorized on the basis of mode of administration into oral medications, topical medications, injections, and others. The oral medication segment is likely to dominate the market since the first line of treatment or medication for erectile dysfunction comprises of oral medication.
The industry participants in USA considerably spend more on R&D activities and also the region has high healthcare investments and government funding. Development in the emerging areas like orphan drugs and biosimilars is likely to promote the demand for regulatory expertise thereby contributing to the growth of erectile dysfunction drugs market in this region. Besides, sedentary lifestyle, hypertension, stress, anxiety, and chronic diseases are other factors responsible for the growth of the market in USA.
The circumstances surrounding erectile dysfunction may be helpful in determining whether a situational or nonorganic factor is involved. Sudden onset, maintenance of nocturnal erections, presence of psychological problems and concurrent major life events or relationship issues may be associated with nonorganic erectile dysfunction. Concurrent medical illnesses and any medications the patient may be taking should be reviewed. Erectile dysfunction is often a component of generalized medical illness and may represent the initial presentation of cardiovascular disease or diabetes. The history may also reveal certain reversible or modifiable risk factors, such as tobacco use or inadequate diabetes control.
Treatments for ED usually can be classified into several categories. Medications – The most common treatment for ED are the oral prescription medications such as Cialis. They work by bringing more blood to the penis to improve the rigidity of erections. Most people are candidates but care should be taken with some medications and cannot be taken with nitrates.
Vacuum erection devices (VED) – These devices work by using negative pressure to the penis and keeping in the penis with an elastic tension ring. VEDs can help most people but can be uncomfortable.
Injectable Medication and Intraurethral Suppositories – The next line of treatments work by placing medications directly into the penis through an injectable or intraurethral suppository. Self-injections work by injecting medication directly into the corporal bodies to induce an erection. Injections work well for most people but the man or his partner must be willing to inject the medication into the penis.
Prosthesis – For those men who wish to achieve an erection but have failed the previous treatments, a penile prosthesis is the final option. Penile implants typically consist of inflatable cylinders that are placed into the corporal bodies of the penis in the operating room. Patient satisfaction is high with penile prostheses and can be a life-changing event for many men.
Determining the potential benefits Cialis, is much more complex than for drugs that are used to treat cancer, heart disease, or high blood pressure, for example, where one of the potential benefits may be increased survival or avoidance of a heart attack or stroke. It is unlikely that untreated ED contributes to decreased survival, even though it may contribute to emotional distress and strained relationships. Weighing the potential benefits of these drugs involves the interactions in a private relationship based on human emotions and a couple’s perception of their quality of life.
There will be many men without erectile dysfunction who will want to try these drugs, seeking to increase their sexual performance. This can only be regarded as risky behavior. Countries like India are the most attractive markets due to the advantages these countries pose like the availability of government support to develop novel drugs thus attracting more number of manufacturers to invest in this region. Besides this, flourishing generic drugs industry, social stigma, growing base of geriatric population, availability of effective treatment methods, high unmet clinical needs, rising disposable income are also some of the other factors accounting for the fastest growth of this region.